Back to Search
Start Over
Engineering a solution for allogeneic CAR-T rejection.
- Source :
-
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Oct 02; Vol. 32 (10), pp. 3204-3206. Date of Electronic Publication: 2024 Sep 11. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Declaration of interests L.A. and M.S.-H. have a patent filed on immunosuppressant-resistant T cells for adoptive immunotherapy (EP2021/072651).
- Subjects :
- Humans
T-Lymphocytes immunology
T-Lymphocytes metabolism
T-Lymphocytes transplantation
Transplantation, Homologous
Animals
Receptors, Antigen, T-Cell genetics
Receptors, Antigen, T-Cell immunology
Receptors, Antigen, T-Cell metabolism
Graft Rejection immunology
Graft Rejection prevention & control
Immunotherapy, Adoptive methods
Receptors, Chimeric Antigen immunology
Receptors, Chimeric Antigen genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1525-0024
- Volume :
- 32
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Molecular therapy : the journal of the American Society of Gene Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 39265578
- Full Text :
- https://doi.org/10.1016/j.ymthe.2024.08.025